01.29.15
Alexion
4Q Revenues: $599.5 million (+36%)
4Q Earnings: $153.3 million (loss of $19.0 million 4Q13)
FY Revenues: $2.2 billion (+44%)
FY Earnings: $656.9 million (earnings were $252.9 million FY13)
Comments: Soliris sales were $599 million in the quarter, up 36% and to $2.2 billion for the year, up 44%. R&D expenses were up 50% to $129.1 million in the quarter and up 62% to $513.8 million for the year.
4Q Revenues: $599.5 million (+36%)
4Q Earnings: $153.3 million (loss of $19.0 million 4Q13)
FY Revenues: $2.2 billion (+44%)
FY Earnings: $656.9 million (earnings were $252.9 million FY13)
Comments: Soliris sales were $599 million in the quarter, up 36% and to $2.2 billion for the year, up 44%. R&D expenses were up 50% to $129.1 million in the quarter and up 62% to $513.8 million for the year.